AI Healthcare Compliance Specialist Interview Questions

A strong answer distinguishes the Privacy Rule, Security Rule, and Breach Notification Rule, and explains minimum-necessary data access in ML pipelines.

The candidate should reference the Safe Harbor and Expert Determination methods and explain re-identification risks in large training corpora.

A good answer explains model cards as standardized documentation of intended use, limitations, fairness metrics, and performance across demographics.

The answer should cover the 18 HIPAA identifiers and examples like unstructured clinical notes, DICOM metadata, or logging of API requests containing patient data.

A solid answer covers the four-tier risk classification and explains that most clinical AI falls under 'high-risk' due to its impact on patient health outcomes.

The answer should cover the IMDRF risk categorization, 510(k), De Novo, and PMA pathways, and mention the Predetermined Change Control Plan concept.

A great answer discusses selecting appropriate fairness metrics (equalized odds, demographic parity, calibration), stratified performance analysis, root-cause investigation of training data, and remediation strategies.

The candidate should describe hazard identification, risk estimation, risk evaluation, and risk control-applied specifically to AI failure modes like false negatives in cancer screening.

Key clauses include purpose limitation, data minimization, sub-processor restrictions, breach notification timelines, audit rights, and data return/deletion obligations.

The answer should explain that intended use defines the regulatory boundary, that marketing claims must stay within it, and that AI drift could cause a product to operate outside its cleared intended use.

A strong answer references the 21st Century Cures Act Section 3060, the four exemption criteria for CDS, and the critical line: does the tool enable the clinician to make independent decisions?

The answer should cover purpose and scope, stakeholder mapping, data governance, fairness evaluation, monitoring plan, and incident response protocols specific to triage.

A good answer covers the algorithm change protocol, the modification assessment, and how the PCCP allows pre-authorized iterative updates without new 510(k) submissions.

The candidate should discuss Article 22 automated decision-making provisions, the role of interpretability tools (SHAP, LIME), and the tension between model performance and explainability.

An excellent answer discusses a centralized AI governance committee, jurisdiction-specific compliance annexes, cross-border data transfer mechanisms, and localized regulatory liaison roles.

The answer should address LLM-specific risks (hallucination, prompt injection, non-determinism), classify the system under SaMD if it influences clinical decisions, discuss human-in-the-loop requirements, and propose monitoring for factual accuracy.

The candidate should describe data-validation gates (PHI checks, consent verification), model-validation gates (fairness thresholds, performance benchmarks), audit-trail requirements, approval workflows, and automated compliance report generation.

A strong answer differentiates between PCCP-compliant retraining, mandatory reporting to the FDA, potential product recall, and the communication obligations to affected healthcare providers and patients.

The answer should cover accuracy and completeness risks, IRB/ethics committee oversight, human-in-the-loop review requirements, data privacy concerns if patient data is used in prompts, and regulatory expectations from ICH-GCP.

The candidate should discuss external validity, WHO guidance on AI transferability, local regulatory requirements, informed consent in resource-limited settings, and the risk of algorithmic colonialism.

A comprehensive answer covers sandbox objectives, scope limitations, real-time monitoring requirements, patient consent mechanisms, sunset clauses, and pathways from sandbox to full regulatory approval.

The answer should address disparate impact analysis across protected classes (race, age, disability), explainability of denial reasons, appeal process implications, and compliance with insurance regulations and anti-discrimination laws.

The answer should discuss clinical workflow implications, the standard of care for sepsis detection, potential medical liability, IEC 62304 software lifecycle requirements, and technical remediation alongside risk documentation.

The candidate should cover incident taxonomy (near-miss, adverse event, sentinel event), severity scoring for AI-specific harms, reporting timelines for FDA MedWatch and EU Vigilance, root-cause analysis methodology, and feedback loops to model retraining.

A strong answer covers data governance in distributed settings, HIPAA Business Associate Agreement implications, model leakage risks, differential privacy integration, institutional IRB coordination, and cross-institutional liability allocation.

The answer should cover immediate patient-safety actions, incident documentation, root-cause analysis, model performance review, regulatory reporting assessment, communication with the AI vendor, and process improvements.

A great answer addresses data provenance requirements, PHI exposure risks, due-diligence documentation, contractual safeguards, potential regulatory non-compliance, and the decision framework for proceeding versus declining the tool.

The answer should address PHI risks in third-party LLM platforms, clinical accuracy liability, the need for an AI acceptable-use policy, staff training, and the creation of sanctioned AI tools with appropriate guardrails.

The candidate should discuss the regulatory distinction between 'diagnoses' and 'assists in detection,' FDA enforcement discretion, off-label marketing risks, clinical validation requirements, and a phased go-to-market strategy.

A strong answer covers model drift monitoring obligations, performance revalidation requirements, documentation of the gap, remediation timeline, stakeholder communication, and policy updates to prevent recurrence.

The answer should address EU AI Act high-risk classification, CE marking under MDR, GDPR compliance, conformity assessment requirements, Notified Body engagement, and differences from FDA clearance.

The answer should cover immediate patient welfare, contractual liability review, incident investigation scope, regulatory reporting, clinical safety review, vendor accountability mechanisms, and policy updates.

A great answer discusses synthetic data fidelity and re-identification risks, IRB requirements, validation of the GAN's output quality, FDA's evolving stance on synthetic data, and documentation requirements.

The candidate should cover model performance metrics, fairness scores, drift indicators, incident counts, regulatory readiness scores, vendor compliance status, and emerging regulatory risks with materiality assessments.

The answer should address internal model review, vendor communication, contingency planning, patient notification assessment, regulatory self-reporting considerations, and alternative vendor evaluation.

A strong answer covers data drift detection (PSI, KS test), prediction drift, feature distribution monitoring, fairness metric tracking over time, and threshold-setting based on clinical impact rather than purely statistical significance.

The candidate should describe document ingestion, chunking strategy, retrieval-augmented generation (RAG), prompt engineering for requirement extraction, and validation against known requirements to catch hallucinations.

The answer should cover SHAP's value for global and local feature importance, the limitations (correlation vs. causation, instability for correlated features, computational cost), and how to complement SHAP with clinical expert validation.

A great answer covers experiment tracking, model registry with stage transitions (staging, approved, production), approval workflows, artifact logging (model cards, fairness reports, validation results), and audit-trail generation.

The candidate should describe the pipeline: commit triggers unit tests for fairness, runs Fairlearn or custom metric checks, gates on configurable thresholds, generates compliance reports as artifacts, and requires manual approval for production deployment.

The answer should cover model card review, dataset composition analysis, evaluation benchmark review, bias probing using the Evaluate library, license compatibility, and documentation of the adoption decision.

A strong answer covers BAA availability, data residency, PHI handling in API calls, model accuracy validation on local data, access logging, and fallback procedures when the model fails.

The candidate should describe experiment logging, hyperparameter tracking, dataset versioning, model checkpoint management, artifact storage, and team access controls that maintain data integrity for regulatory scrutiny.

The answer should cover data pipeline design (event streaming or batch), metric computation (disparate impact ratio, equalized odds), visualization tools, alerting mechanisms (PagerDuty, Slack), and escalation workflows.

A great answer covers consent collection mechanisms, purpose limitation tracking, data subject rights management (access, deletion, portability), cross-border transfer assessments, and integration with the AI data pipeline for real-time consent enforcement.

A strong answer demonstrates assertiveness, ability to quantify risk in business terms, collaboration to find a phased approach, and the organizational outcome of your pushback.

The candidate should demonstrate structured learning, leveraging expert networks, prioritizing actionable knowledge over exhaustive study, and applying the learning to a concrete deliverable.

A great answer shows empathy for both sides, creating shared language, finding win-win solutions, and establishing ongoing communication rituals that prevent future friction.

The answer should cover the recommendation, the resistance faced, how you advocated with evidence, and the outcome that validated your position-ideally showing prevented regulatory exposure.

A strong answer describes specific information sources (regulatory agency newsletters, professional associations, legal alerts), a personal knowledge management system, and how you translate new developments into actionable organizational updates.